BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on Partusisten® intrapartal (fenoterol hydrobromide): Shortage, possible alternative: Partusisten® concentrate for solution for infusion

Active substance: fenoterol hydrobromide

Due to a shortage in the supply of Partusisten® intrapartal the company has published information that the medicinal product Partusisten® concentrate for solution for infusion can be used as an alternative. Partusisten® concentrate for solution for infusion contains the same active substance but in a concentration that is twice as high (50 micrograms/ml instead of 25 micrograms/ml). All other ingredients of the two medicinal products are identical.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 107KB, File is accessible